Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.

Molecular biotechnology - 1 Sept 2021

Rasoulinejad Seyed Ahmad, Maroufi Faezeh

Abstract excerpt

Retinal diseases are the primary reasons for severe visual defects and irreversible blindness. Retinal diseases are also inherited and acquired. Both of them are caused by mutations in genes or disruptions in specific gene expression, which can be treated by gene-editing therapy. Clustered regularly interspaced short palindromic repeats (CRISPR-Cas9) system is a frontier of gene-editing tools with great potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR-Associated Protein 9
Share to Dependovirus
Share to Diabetic Retinopathy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leber Congenital Amaurosis

Share to Macular Degeneration

Share to Retinitis Pigmentosa

Share to RNA, Guide, CRISPR-Cas Systems

Share to Transcription Activator-Like Effector Nucleases

Source

Identifiers

PMID: 34057656
DOI: 10.1007/s12033-021-00345-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.PMID 34057656Read ↗

The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Semantic proximity Read ↗

CRISPR Interference-Potential Application in Retinal Disease.Semantic proximity Read ↗

In Vivo Applications of CRISPR-Based Genome Editing in the RetinaSemantic proximity Read ↗

From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseasesSemantic proximity Read ↗

Therapeutic applications of CRISPR /Cas9 gene editing technology for the treatment of ocular diseasesSemantic proximity Read ↗

CRISPR-Cas9 Gene Therapy Effects on Inherited Eye DisordersSemantic proximity Read ↗

Genome-Editing Strategies for Treating Human Retinal DegenerationsSemantic proximity Read ↗

The application and progression of CRISPR/Cas9 technology in ophthalmological diseasesSemantic proximity Read ↗

Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical StrategiesSemantic proximity Read ↗

Precision genome editing in the eye.Semantic proximity Read ↗

CRISPR Technology for Ocular AngiogenesisSemantic proximity Read ↗

CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.